Masatoshi Ohmae

Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects

Masahiro Kitamura, Motoki Akamatsu, Masamitsu Kawanami et al. · Journal of Bone and Mineral Research · 2015 · 140 citations · Full text

Dentistry, Periodontics, Periodontology +16

Surgical approaches for condylar fractures related to facial nerve injury: deep versus superficial dissection

Tomoaki Imai, Yusei Fujita, Ayako Motoki et al. · International Journal of Oral and Maxillofacial Surgery · 2019 · 28 citations

Dentistry, Maxillofacial Surgery, Surgery +14

Longitudinal study of risk for facial nerve injury in mandibular condyle fracture surgery: marginal mandibular branch-traversing classification of percutaneous approaches

Tomoaki Imai, Yusei Fujita, Ayako Motoki et al. · Clinical Oral Investigations · 2019 · 17 citations

Dentistry, Maxillofacial Surgery, Surgery +15

Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.

Mitsuhiro Nakazawa, Takenao Ohnishi, Masatoshi Ohmae et al. · PubMed · 2005 · 11 citations

Medicine, Oncology, Pharmacology +16